1. Home
  2. EXPI vs VERA Comparison

EXPI vs VERA Comparison

Compare EXPI & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$10.58

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$49.86

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPI
VERA
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EXPI
VERA
Price
$10.58
$49.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$12.00
$67.67
AVG Volume (30 Days)
1.4M
1.8M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
1.89%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,678,653,000.00
N/A
Revenue This Year
$6.03
N/A
Revenue Next Year
$5.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.12
N/A
52 Week Low
$6.90
$18.53
52 Week High
$13.35
$50.16

Technical Indicators

Market Signals
Indicator
EXPI
VERA
Relative Strength Index (RSI) 45.80 83.43
Support Level $10.16 $40.38
Resistance Level $10.71 $47.10
Average True Range (ATR) 0.38 3.35
MACD -0.08 1.34
Stochastic Oscillator 22.06 99.33

Price Performance

Historical Comparison
EXPI
VERA

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: